Susan E. Nozell, Ph.D. - Publications

Affiliations: 
2001 Medical College of Georgia, Augusta, GA, United States 
Area:
Visual Attention

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Boyd NH, Walker K, Fried J, Hackney JR, McDonald PC, Benavides GA, Spina R, Audia A, Scott SE, Libby CJ, Tran AN, Bevensee MO, Griguer C, Nozell S, Gillespie GY, et al. Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo. Jci Insight. 2. PMID 29263302 DOI: 10.1172/Jci.Insight.92928  0.415
2017 Lai YJ, Tsai JC, Tseng YT, Wu MS, Liu WS, Lam HI, Yu JH, Nozell SE, Benveniste EN. Small G protein Rac GTPases regulate the maintenance of glioblastoma stem-like cells in vitro and in vivo. Oncotarget. PMID 28160553 DOI: 10.18632/oncotarget.14949  0.345
2015 Rajbhandari R, McFarland BC, Patel A, Gerigk M, Kenneth Gray G, Fehling SC, Bredel M, Berbari NF, Kim H, Marks MP, Meares GP, Sinha T, Chuang J, Benveniste EN, Nozell SE. Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma Oncotarget. 6: 17805-17816.  0.323
2013 McFarland BC, Hong SW, Rajbhandari R, Twitty GB, Gray GK, Yu H, Benveniste EN, Nozell SE. NF-κB-induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma. Plos One. 8: e78728. PMID 24244348 DOI: 10.1371/journal.pone.0078728  0.325
2011 McFarland BC, Ma JY, Langford CP, Gillespie GY, Yu H, Zheng Y, Nozell SE, Huszar D, Benveniste EN. Therapeutic potential of AZD1480 for the treatment of human glioblastoma. Molecular Cancer Therapeutics. 10: 2384-93. PMID 22027691 DOI: 10.1158/1535-7163.MCT-11-0480  0.435
2011 Zhao X, Laver T, Hong SW, Twitty GB, Devos A, Devos M, Benveniste EN, Nozell SE. An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomas. Journal of Neuro-Oncology. 102: 367-81. PMID 21279667 DOI: 10.1007/S11060-010-0346-Y  0.392
2009 Atkinson GP, Nozell SE, Harrison DK, Stonecypher MS, Chen D, Benveniste EN. The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma. Oncogene. 28: 3735-45. PMID 19668231 DOI: 10.1038/onc.2009.232  0.345
2008 Nozell S, Laver T, Moseley D, Nowoslawski L, De Vos M, Atkinson GP, Harrison K, Nabors LB, Benveniste EN. The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes. Molecular and Cellular Biology. 28: 6632-45. PMID 18779315 DOI: 10.1128/Mcb.00697-08  0.314
2004 Liu G, Nozell S, Xiao H, Chen X. DeltaNp73beta is active in transactivation and growth suppression. Molecular and Cellular Biology. 24: 487-501. PMID 14701724 DOI: 10.1128/Mcb.24.2.487-501.2004  0.39
2003 Nozell S, Wu Y, McNaughton K, Liu G, Willis A, Paik JC, Chen X. Characterization of p73 functional domains necessary for transactivation and growth suppression. Oncogene. 22: 4333-47. PMID 12853970 DOI: 10.1038/Sj.Onc.1206470  0.428
2003 Chen X, Liu G, Zhu J, Jiang J, Nozell S, Willis A. Isolation and characterization of fourteen novel putative and nine known target genes of the p53 family. Cancer Biology & Therapy. 2: 55-62. PMID 12673118 DOI: 10.4161/Cbt.180  0.551
2002 Nozell S, Chen X. p21B, a variant of p21(Waf1/Cip1), is induced by the p53 family. Oncogene. 21: 1285-94. PMID 11850848 DOI: 10.1038/Sj.Onc.1205191  0.335
Show low-probability matches.